Replies to post #133422 on PharmaCyte Biotech Inc (PMCB)

[livendi]

Great post old musky

[DragonBear]

Remember all the testing that went on and on and on

How could one forget the blow by blow accounts for almost every test run in non-ending Kenny PR pumps.

Well guess what. PharmaCyte has done everything the FDA wants

Well guess what...Yet TBD.

They filed the IND confidently.

With the disclaimer in their recent 10Q:

Although no assurance as to the timing of the trial can be given or whether the FDA will allow the Company to commence a Phase 2b clinical trial as opposed to a Phase 1 clinical trial or further preclinical studies.

Doesn't get any more "confidently" than that for Kenny.

All those SUCCESSFUL tests lead me to believe the IND will be accepted.

Yeah the FDA will accept anything. Just run a few QC tests. Nothing else matters.

Not only were the tests successful, but this treatment is for one of the most urgent unmet medical needs

What exactly is this "unmet medical need"? There are treatments available for 2nd line PC.

The FDA wants to find a solution for this disease and other cancers, and diabetes

The FDA doesn't need to find anything. Not their mission.

Once approved things will happen fast.

Once rejected nothing will happen.

Big Pharma will have to notice this and consider an acquisition or get run over by the technology

Highly unlikely Big Pharma will notice a 20 yr old antiquated chemo treatment, and fear being overrun by it. Much less an unproven treatment from 20 yrs ago.

but now the IND has been filed. All systems go.

Yeah, Kenny will be ready to dilute even more.

Dilution will always hurt the stocks performance, but it is how clinical stage bios make money until their treatments go to market. These old gentlemen(execs) will not bring this to market, big Pharma will.

Small biotechs on the Nasdaq have under 100M for their stock O/S. Real biotechs do not dilute like PMCB does.

Again, Pharma is not interested in buying an unproven chemo drug therapy from 20 yrs ago. Research what small cap oncology companies have been bought in the last few years. It involves checkpoint inhibitors, and immunotherapies. They have no interest in buying or bringing to market a product from a Microcrap scam.

The execs will retire rich and happy

That is already a given with their plush salaries.

[tulla236a]

when i first got in, i was thinking pmcb and ciab was worth 3-5 billion and i still do. but o/s at that time was 750 mill so my investment has been cut by a third because of dilution. ok so my expectations went from $4.00-$6.00 a share down to $1.50-$2.00. that hurts but i'll take it.

who knows, if ind get approved and the pps stays the same, i may add some more. the odds keep getting better.